Camurus AB Sustainability Reports
Camurus AB is a science-led biopharmaceutical company that develops and commercializes innovative, long-acting medicines for serious and chronic conditions, such as opioid dependence and rare endocrine diseases. The company utilizes its proprietary FluidCrystal drug delivery technology to provide advanced subcutaneous depot treatments.
Sector: Manufacturing
Country: Sweden
Exchange: Nasdaq Stockholm
LEI: 5493003S6Z6VI7WYFQ06
FIGI: BBG00732K0F7
11 reports from 2015 to 2025
